Skip to main content
Download PDF
- Main
Sugammadex vs Neostigmine: Possible Decrease in PACU Stay
The data associated with this publication are not available for this reason: N/A
Abstract
• Neostigmine – longstanding only choice for reversal of neuromuscular blockade
• Incomplete reversal and residual neuromuscular blockade: atelectasis, pulmonary edema, desaturations, postoperative pulmonary complications, and longer hospital stay
• March 2016: sugammadex introduced at UCDMC
• Sugammadex can rapidly reverse even deep neuromuscular blockade and is associated with fewer adverse events: decreased surgery duration, PACU stay, and overall hospital stay2
• This study aims to compare patient flow -neostigmine versus sugammadex end of surgery to PACU total PACU stay